Liberty Analytics Co. Initiates Independent Research Coverage on EDAP TMS S.A.
2010年3月10日 - 3:15PM
Liberty Analytics Co., a leading provider of large, small- and
micro-cap independent investment research, today initiated coverage
on EDAP TMS S.A. (Nasdaq:EDAP). Liberty Analytics is currently
offering a complimentary trial subscription. To view our research,
go to: www.libertyanalyticsco.com.
About LAC:
Liberty Analytics Co. is a leading provider of independent
investment research in North America. Our services include research
analysis on the large, small- and micro-cap markets, real-time news
and financial data, market commentary and the LAC newsletter.
Liberty Analytics' staff of large and small-cap investment
professionals is dedicated to providing the market's investment
community with the tools and avenues necessary to make the
important investment decisions. To view our research reports on a
complimentary trial basis and take advantage of our other services,
go to www.libertyanalyticsco.com and click on the complimentary
trial subscription button on our home page, or go directly to our
registration page at www.libertyanalyticsco.com/signup.php.
About EDAP TMS S.A. (Nasdaq:EDAP)
EDAP TMS S.A. (Nasdaq:EDAP) is a holding company that
develops, produces and markets minimally invasive medical devices,
mainly for urological diseases through two divisions: High
Intensity Focused Ultrasound (HIFU) Division and Urology Devices
and Services (UDS) Division.
LAC Disclosure:
Libertyanalyticsco.com is not a registered investment advisor
and nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. Liberty Analytics has
not been compensated by any of the above-mentioned companies.
Please read our report and visit our Web site,
www.libertyanalyticsco.com, for complete risks and disclosures.
CONTACT: Liberty Analytics
Kevin Mix
480-626-1850
info@libertyanalyticsco.com
EDAP TMS (NASDAQ:EDAP)
過去 株価チャート
から 9 2024 まで 10 2024
EDAP TMS (NASDAQ:EDAP)
過去 株価チャート
から 10 2023 まで 10 2024